Table 1

Characteristics of the included studies

StudyDesignCountryYears of data collectionNumber of participantsAge (mean, SD)Previous PSA screeningFamily history of prostate cancer
Studies reporting direct choice related to PSA screening acceptability
 Cantor et al 24 DCEUSA1997–199816856 (NR)Ever=50%
17% have relative with prostate cancer
 de Bekker-Grob et al 25 DCEThe Netherlands2013100063.3 (5.2)NR51% know someone with prostate cancer
 Howard et al 26 and Pignone et al 29 DCEAustralia and USA201191159.8 (5.6)Ever=20.9%
Within past year=42%
 Howard et al 27 DCEUSANR66255 (9)Ever=44.6%
Within past year=28.1%
 van den Bruel et al 28 DCEUK201449046.9 (range: 19–87)Ever=53.8%NR
Studies of decision aids reporting men’s willingness to undergo PSA screening
 Gattellari and Ward30 RCTAustraliaNR25854 (8.55)NRNR
 Petrova et al 31 RCTUSANR25636 (13)Ever=18%27% had a friend or a relative diagnosed with prostate cancer
 Sheridan et al 32 RCTUSANR18860 (9)Ever=70%20% had any family history
 Sheridan et al 33 RCTUSANR775NREver=80%NR
 Taylor et al 34 RCTUSA2007–2011189356.9 (6.8)Ever=86.3%
Within past year=59.3%
23% had family history
 Wilt et al 35 RCTUSA199834272.8 (8.4)Within past year=31%14%
  • DCE, discrete choice experiment; NR, not reported; PSA, prostate-specific antigen; RCT, randomised controlled trial.